美國
US 12,697,351 B2
Method of treating conditions, reducing an inflammatory response, or improving organ function in a subject having a corona virus infection by administering an inhibitor of C5a activity
US 12,697,351 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-04。申請人：InflaRx GmbH。PDF 可在本頁下載，未登入每天最多 5 篇。
- 申請人
- InflaRx GmbH
- 發明人
- Niels C. RIEDEMANN; Renfeng GUO
- 公開日
- 2026-08-04
- 申請日
- 2022-09-26
- 文件種類
- B2 核准公告
- 也寫作
- US 12,697,351 B2 · US12697351 · 12697351
摘要
The present invention relates to an inhibitor of C5a activity medical condition caused by or associated with infection with a corona virus. The invention also relates to the use of an inhibitor of C5a activity in the reduction of an inflammatory response in a subject suffering from a corona virus infection. The invention further relates to an inhibitor of C5a activity for use in the improvement of organ function, in particular lung function and/or hepatic function, in a subject suffering from a corona virus infection.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）